Details for New Drug Application (NDA): 205897
✉ Email this page to a colleague
The generic ingredient in PRASUGREL is prasugrel hydrochloride. There are nineteen drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the prasugrel hydrochloride profile page.
Summary for 205897
Tradename: | PRASUGREL |
Applicant: | Panacea |
Ingredient: | prasugrel hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 205897
Mechanism of Action | P2Y12 Receptor Antagonists |
Physiological Effect | Decreased Platelet Aggregation |
Medical Subject Heading (MeSH) Categories for 205897
Suppliers and Packaging for NDA: 205897
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PRASUGREL | prasugrel hydrochloride | TABLET;ORAL | 205897 | ANDA | Panacea Biotec Limited | 43817-239 | 43817-239-01 | 30 TABLET, FILM COATED in 1 BOTTLE (43817-239-01) |
PRASUGREL | prasugrel hydrochloride | TABLET;ORAL | 205897 | ANDA | Panacea Biotec Limited | 43817-240 | 43817-240-01 | 30 TABLET, FILM COATED in 1 BOTTLE (43817-240-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 5MG BASE | ||||
Approval Date: | Oct 16, 2017 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | EQ 10MG BASE | ||||
Approval Date: | Oct 16, 2017 | TE: | AB | RLD: | No |
Complete Access Available with Subscription